Role of high molecular weight kininogen in contact activation.
D000209:Acute-Phase Proteins / Q000502:physiology; D000818:Animals; D001777:Blood Coagulation; D001792:Blood Platelets / Q000166:cytology / Q000502:physiology; D003001:Cloning, Molecular; D015853:Cysteine Proteinase Inhibitors; D004727:Endothelium / Q000166:cytology; D005172:Factor XI / Q000037:antagonists & inhibitors / Q000502:physiology; D015945:Factor XIa; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors; D007704:Kininogens / Q000037:antagonists & inhibitors / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology*; D008970:Molecular Weight; D011288:Prekallikrein / Q000502:physiology; D011506:Proteins / Q000502:physiology; D051381:Rats; D013329:Structure-Activity Relationship
D000209:Acute-Phase Proteins; D015853:Cysteine Proteinase Inhibitors; D007704:Kininogens; D011506:Proteins; D005172:Factor XI; D011288:Prekallikrein; D007610:Kallikreins; D015945:Factor XIa